Kapitel 1

[1] http://www.biotechacademy.dk

[2] Kiecolt-Glaser, J et al. Lancet 346:1194-1195. 1995

[3] Oliver RT, Nethersell AB et al. Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma. Br J Urol. 1989 Feb;63(2):128-31.
Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet. 1986 Jun;162(6):603-10.

[4] Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245–70.

Hamerman D. Toward an understanding of frailty.Ann Intern Med. 1999 Jun 1;130(11):945–50.

Taaffe DR, Harris TB, et al. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A BiolSci Med Sci. 2000 Dec;55(12):M709–M715.

[5] DelaFuente M, Ferrández M, et al. Immune function in aged women is improved by ingestion of vitamins C and E. Can J PhysiolPharmacol. 1998;(76):373–80.

[6] Knuth A, Wolfel T et al. Cellular and humoral immune responses against cancer: implications for cancer vaccines. Curr Opin Immunol. 1991 Oct;3(5):659-64

Naftzger C, Houghton AN. Tumor immunology. Curr Opin Oncol. 1991 Feb;3(1):93-9.

[7] Kiecolt-Glaser J, McGuire L, et al. Psychoneuroimmunology and psychosomatic medicine: back to the future. Psychosom Med. 2000;(641):15–28.

[8] Ironson G, LaPerriere A, et al. Changes in immune and psychological measures as a function of anticipation and reaction to news of HIV-1 antibody status. Psychosom Med. 1990 May;52(3):247–70.

Koh KB, Lee BK. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom Med. 1998 Jul;60(4):479–83.

Boscarino JA, Chang J. Higher abnormal leukocyte and lymphocyte counts 20 years after exposure to severe stress: research and clinical implications. Psychosom Med. 1999 May;61(3):378–86.

[9] Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics. 2004 Jan 15;16(2):166–77.

[10] LutgendorfSK , Garand L, et al. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A BiolSci Med Sci. 1999 Sep;54(9):M434–M439.

[11] Lerman Y, Melamed S, et al. Association between burnout at work and leukocyte adhesiveness/aggregation. Psychosom Med. 1999 Nov;61(6):828–33.

[12] Arnetz BB, Brenner SO, et al. Neuroendocrine and immunologic effects of unemployment and job insecurity. PsychotherPsychosom. 1991;55(2–4):76–80.

[13] Kiecolt-Glaser JK, Fisher LD, et al. Marital quality, marital disruption, and immune function.Psychosom Med. 1987 Jan;49(1):13–34.

Kiecolt-Glaser JK, Glaser R, et al. Marital conflict in older adults: endocrinological and immunological correlates. Psychosom Med. 1997 Jul;59(4):339–49.

Kiecolt-Glaser JK, Kennedy S, et al. Marital discord and immunity in males. Psychosom Med. 1988 May;50(3):213–29.

Kiecolt-Glaser JK, Malarkey WB, et al. Negative behavior during marital conflict is associated with immunological down-regulation. Psychosom Med. 1993 Sep;55(5):395–409.

[14] Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics. 2004 Jan 15;16(2):166–77.

[15] Appels A, Bar FW, et al. Inflammation, depressive symptomtology, and coronary artery disease.Psychosom Med. 2000 Sep;62(5):601–5.

Zhou D, Kusnecov AW, et al. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993 Dec;133(6):2523–30.

Papanicolaou DA, Wilder RL, et al. The pathophysiologic roles of interleukin-6 in human disease.Ann Intern Med. 1998 Jan 15;128(2):127–37.

[16] Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics. 2004 Jan 15;16(2):166–77.

Ames BN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001 Apr 18;475(1–2):7–20.

[17] Hebert, J., Rosen, A.: Nutritional, socioeconomic and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. Cancer Detction Prevention 1996; 20: 234-44.

[18] Brandt B, Hermann S, Straif K, Tidow N, Buerger H, Chang-Claude J. Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene. Cancer Res. 2004 Jan 1;64(1):7-12.
Shannon J, Cook LS, Stanford JL. Dietary intake and risk of postmenopausal breast cancer (United States). Cancer Causes Control. 2003 Feb;14(1):19-27.
Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet. 1991 May 18;337(8751):1197-1200.
Dos Santos SI, Mangtani P, McCormack V, et al. Lifelong vegetarianism and risk of breast cancer: a population-based case-control study among South Asian migrant women living in England. Int J Cancer. 2002; 99:238-44.
Toniolo P, Riboli E, Shore RE, Pasternack BS. Consumption of meat, animal products, protein, and fat and risk of breast cancer: a prospective cohort study in New York. Epidemiology. 1994 Jul;5(4):391-7.
Cho E, Spiegelman D, Hunter DJ, et al. Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst. 2003 Jul 16;95(14):1079-85.

[19] Djuric Z, Depper JB, Uhley V, Smith D, Lababidi S, Martino S, Heilbrun LK. Oxidative DNA damage levels in blood from women at high risk for breast cancer are associated with dietary intakes of meats, veg- etables, and fruits. J Am Diet Assoc. 1998 May;98(5):524-8.

[20] http://www.dietandcancerreport.org/

http://www.naturalnews.com/022288_sodium_nitrite_processed_meat.html

[21] Annie N. Samraj, Oliver M. T. Pearcea, Heinz Läubli et al.: A red meat-derived glycan promotes inflammation and cancer progression. Published online before print December 29, 2014, doi: 10.1073/pnas.1417508112
PNAS December 29, 2014. http://videnskab.dk/kort-nyt/sukker-i-rodt-kod-kan-vaere-arsag-til-kraeftfare

[22]William B. Grant A Multicountry Ecological Study of Cancer Incidence Rates in 2008 with Respect to Various Risk-Modifying Factors. Nutrients 2014, 6(1), 163-189; doi:10.3390/nu6010163

http://www.mdpi.com/2072-6643/6/1/163

[23] Barnard ND1Nicholson AHoward JL.: The medical costs attributable to meat consumption.

Prev Med. 1995 Nov;24(6):646-55. http://www.ncbi.nlm.nih.gov/pubmed/8610089

http://www.birdflubook.org/resources/Barnard_1995_PM_24_646.pdf

http://www.collective-evolution.com/2015/02/11/how-cancer-tumors-use-meat-to-fuel-their-growth/

[24] http://www.pnas.org/content/105/48/18936.full.pdf+html

[25] http://www.dietandcancerreport.org/cancer_resource_center/downloads/summary/english.pdf

[26] Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004 Feb;7(1A):187-200.

Gonzalez CA. Nutrition and cancer: the current epidemiological evidence. Br J Nutr. 2006 Aug;96 Suppl 1:S42-5.

Tetè S, Nicoletti M, Saggini A, et al. Nutrition and cancer prevention. Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):573-81.

[27] Ronco AL, De Stefani E, Deneo-Pellegrini H. Risk factors for premenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev . 2012;13(6):2879-86.

Cui X, Dai Q, Tseng M, Shu XO, Gao YT, Zheng W. Dietary patterns and breast cancer risk in the shanghai breast cancer study. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1443-8.

De Stefani E. Ronco A. Mendilaharsu M. Guidobono M. Deneo-Pellegrini H. Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidem, Biomarkers Prev. 6(8):573-81, 1997. Block s. 66

[28] Cui X, Dai Q, Tseng M, Shu XO, Gao YT, Zheng W. Dietary patterns and breast cancer risk in the shanghai breast cancer study. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1443-8.

[29] Shannon J, Ray R, Wu C, etal. Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):81-90.

[30] Cho E, Chen WY, Hunter DJ, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med. 2006 Nov 13;166(20):2253-9.

[31] Colditz GA, Rosner BA, Chen WY, Homes MD, Hankinson, SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.

[32] Ponnampalam EN, Mann NJ, Sinclair AJ. Effect of feeding systems on omega-3 fatty acids, conjugated linoleic acid and trans fatty acids in Australian beef cuts: potential impact on human health. Asia Pac J Clin Nutr. 2006;15(1):21-9.

[33] American Journal of Clinical Nutrition  December 2006

[34] Hebert JR. Hurley TG. Ma Y. The effect of dietary exposures on recurrence and

mortality in early stage breast cancer. Breast Cancer Res Treat. 1998;51(1):17-28. Her i Keith I. Block 2009

[35] Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, Woods MN. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New Eng J Med 1982; 307: 1542

Armstrong B, Brown J, Clarke H, et al: Diet and reproductive hormones: A study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 67: 761-767, 1981

Wu A, Pike M, Stram D: Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91: 529-534, 1999

Sacks FM. Castelli WP. Donner A. Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. New Engl J Med. 292(22):1148-51, 1975

Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002; 20(15):3302-16. Block 2009

[36] http://samvirke.dk/mad/brevkasse/hvorfor-kan-faa-koedpaalaeg-uden-nitrit.html

[37] http://lifeovercancer.wordpress.com/2013/05/22/planning-a-bbq-what-you-need-to-know-before-firing-up-the-grill/

[38] Smith JS, Ameri F, Gadgil P: Effect of marinades on the formation of heterocyclic amines in grilled beef steaks. J Food Sci 2008 Aug; 73(6) :T100-5. http://www.ncbi.nlm.nih.gov/pubmed/19241593

[39] http://www.liveinthenow.com/article/why-marinating-your-meat-might-save-you-from-cancer

[40] Viegas O, Amaro LF, Ferreira IM, et al.  Inhibitory effect of antioxidant-rich marinades on the formation of heterocyclic aromatic amines in pan-fried beef. J Agric Food Chem 2012 Jun 20; 60(24) :6235-40.

[41] A. Farhadian, S. Jinap, A. Faridah, I.S.M. Zaidul: Effects of marinating on the formation of polycyclic aromatic hydrocarbons (benzo[a]pyrene, benzo[b]fluoranthene and fluoranthene) in grilled beef meat. Food Control

Volume 28, Issue 2, December 2012, Pages 420–425. http://www.sciencedirect.com/science/article/pii/S0956713512002071

 

[43] Pedersen GS1, Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA.: Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res Treat. 2010 Jul;122(1):199-210. doi: 10.1007/s10549-009-0642-4. Epub 2009 Dec 1.

http://www.ncbi.nlm.nih.gov/pubmed/19949857

[44] Anja Olsen, Jane Christensen, Malene Outzen, Pelle Thonning Olesen, Henrik Frandsen, Kim Overvad, Jytte Halkjær Pre-diagnostic acrylamide exposure and survival after breast cancer among postmenopausal Danish women. Toxicology. 2012 Jun 14 ;296(1-3):67-72. Epub 2012 Mar 20. PMID: 22465873

[45] http://videnskab.dk/krop-sundhed/ny-bekymring-over-kraeftfremkaldende-stf-i-fodevarer

[46] Kit Granby: Akrylamid i maden kan øge risikoen for at udvikle kræft. DTU Fødevareinstituttet. http://www.food.dtu.dk/Nyheder/2014/07/Akrylamid-i-maden-kan-oege-risikoen-for-at-udvikle-kraeft

[47] Donald B. Jump, Ph.D. Professor of Nutrition and Exercise Sciences
LPI Principal Investigator: WHAT’S GOOD ABOUT DIETARY FAT? http://lpi.oregonstate.edu/ss08/fat.html

[48] http://www.avogel.dk/advice/Hancke_artikler/Fedt_i_julemaden.php?utm_source=apsis-anp-3&utm_medium=email&utm_content=unspecified&utm_campaign=unspecified

[49] http://lifeovercancerblog.typepad.com/life-over-cancer-blog/2013/02/good-fats-bad-fats-which-is-which.html

[50] Howe, GR. Et al.: Dietary factors and risk of breast cancer: Combined analysis of 12 case-control studies. J Natl Cancer Inst 82:561-569. 1990. Her fra: Her fra: Carylyn Clifford et al.: Diet and Cancer Risk http://rex.nci.nih.gov/NCI Pub Interface/raterisk/risks76.html

[51] Chan KC, Lou PP, Hargrove JL. High casein-lactalbumin diet accelerates blood coagulation in rats. J Nutr. 1993;123(6):1010-6.

Mezzano D, Munoz X, Martinez C, Cuevas A, Panes O, Aranda E, Guasch V, Strobel P, Munoz B, Rodriguez S, Pereira J, Leighton F. Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine. Thromb Haemost. 1999;81(6):913-7.

[52] Hebert JR. Barone J. Reddy MM. Backlund JY. Natural killer cell activity in a longitudinal dietary fat intervention trial. Clinical Immunology & Immunopathology. 1990; 54(1):103-16

Malter M. Schriever G. Eilber U. Natural killer cells, vitamins, and other blood

components of vegetarian and omnivorous men. Nutrition & Cancer. 1989; 12(3):271-8

Vujanovic NL. Basse P. Herberman RB. Whiteside TL. Antitumor functions of natural killer cells and control of metastases. Methods (Duluth). 9(2):394-408, 1996. Block s. 57

[53] http://radiodoktoren.dk/radiodoktoren/2013/07/21/utaet-tarm

[54] Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, Woods MN. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. New Eng J Med 1982; 307: 1542

Armstrong B, Brown J, Clarke H, et al: Diet and reproductive hormones: A study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 67: 761-767, 1981

Wu A, Pike M, Stram D: Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst 91: 529-534, 1999.

[55] Gregorio DI. Emrich LJ. Graham S. Marshall JR. Nemoto T.   Dietary fat consumption and survival among women with breast cancer. J Nat Cancer Inst. 1985 ; 75(1):37-41.

[56] Chlebowski RT, Blackburn GL, Thomson CA, et al.: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst. 2006; 98(24):1767-76.

[57] Zhang S. Folsom AR. Sellers TA. et al. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer. 1995; 76(2):275-83.

[58] Jain M. Miller AB. To T. Premorbid diet and the prognosis of women with breast cancer. J Natl Cancer Inst. 1994; 86(18):1390-7.

[59] Ogilvie GK, Fettman MJ, Mallinckrodt CH et al.: Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Cancer 2000;88(8):1916-28.

[60] Baronzio G. Freitas I. Griffini P. Bertone V. Pacini F. Mascaro G. Razzini E. Gramaglia A. Omega-3 fatty acids can improve radioresponse modifying tumor interstitial pressure, blood rheology and membrane peroxidability. Anticancer Res. 1994; 14(3A):1145-54.

Gutt CN, Brinkmann L, Mehrabi A et al.: Dietary omega-3-polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver. Eur J Nutr. 2007 Aug;46(5):279-85.

[61] Ip C.: Controversial issues of dietary fat and experimental mammery carcinogenesis. Prev Med 22:728-737. 1993.

[62] Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57(2):253-8. Block 2009

[63] Wallace JM. Nutritional and botanical modulation of the inflammatory cascade – eicosanoids, cyclooxygenases, and lipoxygenases – as an adjunct in cancer therapy. Integr Cancer Ther. 2002; 1(1):7-37. Block 2009

[64] Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol. 2005 Mar;16(3):359-71.

[65] Lajous M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I. Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women. Am J Clin Nutr. 2008 May;87(5):1384-91.

[66] Mulligan AM, O’Malley FP, Ennis M, Fantus IG, Goodwin PJ. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat. 2007 Nov;106(1):39-47.

[67] Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002 Jan 1;20(1):42-51.

[68] Emond JA, Pierce JP, Natarajan L, et al. Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGF-1 Receptor. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1273-9.

[69] Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp. 2004;262:247-60; discussion 260-8.

Melnik BC, John SM, Schmitz G. (2011). Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome. Nutr Metab. 2011;8(1):41.

[70] Emond JA, Pierce JP, Natarajan L, et al. Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGF-1 Receptor. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1273-9

[71] Chau CF, Yang P, Yu CM, Yen GC. Investigation on the lipid- and cholesterol-lowering abilities of biocellulose. J Agric Food Chem. 2008 Mar 26;56(6):2291-5.

Sadiq Butt M, Tahir-Nadeem M, Khan MK, Shabir R, Butt MS. Oat: unique among the cereals. Eur J Nutr. 2008 Mar;47(2):68-79.

Wells CL, Barton RG, Jechorek RP, Gillingham KJ, Cerra FB. Effect of fiber supplementation of liquid diet on cecal bacteria and bacterial translocation in mice. Nutrition. 1992 Jul-Aug;8(4):266-71.

Kestell P, Zhao L, Zhu S, Harris PJ, Ferguson LR. Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis. 1999 Dec;20(12):2253-60.

[72] Nilsson AC, Ostman EM, Holst JJ, Björck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr. 2008 Apr;138(4):732-9.

Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 2008 Mar;138(3):439-42.

[73] McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer. 2006;55(2):132-40.

[74] Boyd DB. Insulin and cancer. Integr Cancer Ther. 2003 Dec;2(4):315-29.

[75] Nicholas A Graham, Martik Tahmasian, Bitika Kohli, Evangelia Komisopoulou, Maggie Zhu, Igor Vivanco, Michael A Teitell, Hong Wu, Antoni Ribas, Roger S Lo, Ingo K Mellinghoff, Paul S Mischel, Thomas G Graeber. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Molecular Systems Biology, 2012; 8 DOI: 10.1038/msb.2012.20

[76] Rainer J Klement and Ulrike Kämmerer; Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond). 2011; 8: 75; Published online 2011 October 26. doi: 10.1186/1743-7075-8-75 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267662/?tool=pubmed

[77] http://www.greenmedinfo.com/blog/cancer-sugar-strategy-selective-starvation-cancer

[78] Boyd DB. Insulin and cancer. Integr Cancer Ther. 2003 Dec;2(4):315-29.

[79] Jacki Glew, MS, RD, LDN, is the clinical nutrition manager at the Block Center for Integrative Cancer Treatment. She and four other dietitians work daily with the Block Center’s integrative staff. http://lifeovercancerblog.typepad.com/life-over-cancer-blog/2011/01/does-sugar-feed-cancer.html

[80] Christine Horner, MD: High Insulin and Sugar Increases Breast Cancer Risk

http://www.newliving.com/issues/aug-2005/articles/breast%20cancer.html

http://www.greenmedinfo.com/blog/cancer-sugar-strategy-selective-starvation-cancer

[81] Cancer-related inflammationMantovani A, Allavena P, Sica A, Balkwill F.; Nature. 2008 Jul 24;454(7203):436-44; http://www.ncbi.nlm.nih.gov/pubmed/18650914

http://www.greenmedinfo.com/blog/cancer-sugar-strategy-selective-starvation-cancer

[82] Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S. The serum insulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1986;29(11):784-91.

[83] Hoppe C, Molgaard C, Michaelsen KF. Cow’s milk and linear growth in industrialized and developing countries. Ann Rev Nutr. 2006; 26:131-73.

Hoppe C, Molgaard C, Vaag A, Barkholt V, Michaelsen KF. High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr. 2005; 59(3):393-8.

[84] Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002 Sep;11(9):852-61

Heaney RP, McCarron DA, Dawson-Hughes B, Oparil S, Berga SL, Stern JS, Barr SI, Rosen CJ. Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc. 1999;99(10):1228-33.

Cadogan J, Eastell R, Jones N, Barker ME. Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial. BMJ. 1997; 315(7118):1255-60.

[85] Outwater JL, Nicholson A, Barnard N. Dairy products and breast cancer: the IGF-I, estrogen, and bGH hypothesis. Med Hypotheses. 1997;48(6):453-61.

[86] Juskevich, J.C., Guyer, C.G. (FDA). Bovine growth hormone food safety evaluation. Science 1990:249:875-884.
Mepham, T.B. Public health implications of Bovine somatotropin use in dairying: discussion paper. J. Royal Soc. Medicine 1992:85:736-739
Donovan, S.M. and Odle J., 1994. Growth Factors in Milk as mediators of Infant development. Annual Review of infant development. Annual Review of Nutrion, 14:147-67.

[87] Gannon MC, Nuttall FQ, Krezowski PA, Billington CJ, Parker S. The serum insulin and plasma glucose responses to milk and fruit products in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1986;29(11):784-91.

Lljeberg Elmstagahl H, Bjorck I. Milk as a supplement to mixed meals may elevate postprandial insulnemia Eur J Clin Nutr 2001; 55:994-9.

[88] Lawlor DA, Ebrahim S, Timpson N, Davey Smith G. “Avoiding milk is associated with a reduced risk of insulin resistance and the metabolic syndrome: findings from the British Women’s Heart and Health Study.” Diabetic Med. 2005; 22(6):808-11.

[89] Osterlund P, Ruotsalainen T, Peuhkuri K, Korpela R, Ollus A, Ikonen M, Joensuu H, Elomaa I. Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol. 2004 Aug;2(8):696-703. Her i Keith I. Block 2009

[90] Knight EM, Nzelibe G, Criss W. Effect of salicylamide on the growth of a Morris hepatoma in rats fed 8% and 25% casein diets. Drug Nutr Interact. 1983;2(2):87-94.

Hawrylewicz EJ. Huang HH. Liu JM. Dietary protein, enhancement of N-nitrosomethylurea-induced mammary carcinogenesis, and their effect on hormone regulation in rats. Cancer Res. 1986; 46(9):4395-9.

Cohen MD. Bryant M. Copeland EM 3rd. Mahaffey SM. Kao KJ. Baumgartner TG. Wei CI. Sitren HS. Total parenteral nutrition in mice bearing a metastatic carcinoma: tumor growth, metastasis and immunologic parameters. Clin Exp Metastasis. 1986;4(4):245-57.

Mahaffey SM. Copeland EM 3rd. Economides E. Talbert JL. Baumgartner TG. Sitren HS. The effect of energy substrate manipulation on tumor growth and metastasis and intermediary metabolism in the parenterally fed mouse. J Pediatr Surg. 1985;20(6):775-84.

[91] Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000 Nov-Dec;20(6C):4785-92.

Xiao R, Carter JA, Linz AL, Ferguson M, Badger TM, Simmen FA. Dietary whey protein lowers serum C-peptide concentration and duodenal SREBP-1c mRNA abundance, and reduces occurrence of duodenal tumors and colon aberrant crypt foci in azoxymethane-treated male rats. J Nutr Biochem. 2006 Sep;17(9):626-34.

[92] Marshall K. Therapeutic applications of whey protein. Altern Med Rev. 2004 Jun;9(2):136-56.

[93] Søgaard, Ane Bodil, Karen Østergaard og Troels V. Østergaard: Hvad er det du drikker? Books on Demand u.å.

[94] Boyd DB. Insulin and cancer. Integr Cancer Ther. 2003 Dec;2(4):315-29.

[95] Friedenreich, C.M., Howe, G.R., Miller, A.B. og Jain, M.G.: A cohort study of alcohol consumption and risk of breast cancer. American Journal of Epidemiology 137(5): 512-520. 1993.

Willett, W.C., Stampfer, M.J., Colditz, G.A., Rosner, B.A., Hennekens, C.H., Speizer, F.E.: Moderate alcohol consumption and the risk og breast cancer. New England Journal of medicine 316(19):1174-1180. 1987

Schatzkin, A., Jones, D.Y., Hoover, R.N., Taylor, P.R., Brinton, L.A., Ziegler, R.G., Harvey, E.B., Carter, C.L., Licitra, L.M., Dufour, M.C. og Larson, D.B.: Alcohol consumption and breast cancer in the Epedimiological Follow-up Study of the First National Health and Nutrition Examination Survey. New England Journal of Medicine 316(19): 1169-1173.1987.

[96] Reichman, M.E., Judd, J.T., Longcope, C., Schatzkin, A., Clevidence, B.A., Nair, P.P.m og Taylor, P.R.: Effects of alcohol consumption on plasma and urinary hormone concentrations in postmenopausal women. Journal of the National Cancer Institute 85(9): 722-727. 1993.

[97] http://www.cancer.dk/Nyheder/nyhedsartikler/2011kv4/alkohologbrystkraeft.htm

[98] American Institute for Cancer Research. e-Newsletter May 2008.

[99] Interview gengivet i Mirakelkost af Jean Carper.

[100] 18/5-2006 Healthnotes Newswire, Maureen Williams, ND

[101] Msiska Z, Pacurari M, Mishra A, Leonard SS, Castranova V, Vallyathan V. DNA double-strand breaks by asbestos, silica, and titanium dioxide: possible biomarker of carcinogenic potential? Am J Respir Cell Mol Biol. 2010 Aug;43(2):210-9.

Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K, Yamamoto M. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol. 2001 Jun 15;173(3):154-60.

Rengasamy A, Barger MW, Kane E, Ma JK, Castranova V, Ma JY. Diesel exhaust particle-induced alterations of pulmonary phase I and phase II enzymes of rats. J Toxicol Environ Health A. 2003 Jan 24;66(2):153-67.

Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003090-pdf.pdf.  Accessed on January 3, 2013.

[102] McClellan RO. Health effects of exposure to diesel exhaust particles. Annu Rev Pharmacol Toxicol. 1987;27:279-300.

Mrema EJ, Rubino FM, Brambilla G, Moretto A, Tsatsakis AM, Colosio C. Persistent organochlorinated pesticides and mechanisms of their toxicity. Toxicology. 2012 Dec 3.

[103] Talska G et al. 1994.

[104] Rose DP. Connolly JM. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer. 37(2):119-27, 2000.

[105] Shin SR, Sanchez-Velar N, Sherr DH, Sonenshein GE. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. Cancer Res. 2006 Mar 1;66(5):2570-5.

Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008 Feb;114(1):71-83.

Enwonwu CO, Meeks VI. Bionutrition and oral cancer in humans. Crit Rev Oral Biol Med. 1995;6(1):5-17.

[106] Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004 Sep 23;431(7007):461-6.

[107] Prasad S, Ravindran J, Aggarwal BB. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem. 2010 Mar;336(1-2):25-37.

[108] Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene. 2001 Mar 15;20(11):1287-99.

[109] Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001 Aug;130(2):143-50.

[110] Shin SR, Sanchez-Velar N, Sherr DH, Sonenshein GE. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB. Cancer Res. 2006 Mar 1;66(5):2570-5.

Pratt MA, Tibbo E, Robertson SJ, et al. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene. 2009 Jul 30;28(30):2710-22.

[111] Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene. 2001 Mar 15;20(11):1287-99.

Li SH, Hawthorne VS, Neal CL, et al. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. Cancer Res. 2009 Dec 15;69(24):9163-8.

Brantley DM, Chen CL, Muraoka RS, et al. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell. 2001 May;12(5):1445-55.

[112] deGraffenried LA, Chandrasekar B, Friedrichs WE, et al. NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol. 2004 Jun;15(6):885-90.

[113] Hagemann T, Wilson J, Kulbe H, et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol. 2005 Jul 15;175(2):1197-205.

Liu M, Ju X, Willmarth NE, et al. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Am J Pathol. 2009 May;174(5):1910-20.

Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett. 2010 Dec 28;299(2):137-49.

[114] Prasad S, Ravindran J, Aggarwal BB. NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem. 2010 Mar;336(1-2):25-37.

[115] Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene. 2001 Mar 15;20(11):1287-99.

[116] Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004 Sep 23;431(7007):461-6.

[117] Aravindaram K, Yang NS. Anti-inflammatory plant natural products for cancer therapy. Planta Med. 2010 Aug;76(11):1103-17.

[118] Inflammation and Chrinic Disease – putting out the fire with Omega-3. www.unconventionalhealth.com

[119] Aleksandrova K, Nimptsch K, Pischon T. Obesity and colorectal cancer. Frontiers in bioscience. 2013;5:61-77.

Giles ED, Wellberg EA, Astling DP, Anderson SM, Thor AD, Jindal S, . . . Maclean PS. Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer research. Dec 15 2012;72(24):6490-6501.

Allott EH, Masko EM, Freedland SJ. Obesity and Prostate Cancer: Weighing the Evidence. European urology. Nov 15 2012.

Gribovskaja-Rupp I, Kosinski L, Ludwig KA. Obesity and colorectal cancer. Clinics in colon and rectal surgery. Dec 2011;24(4):229-243.

[120] Schrager, M. A., Metter, E. J., Simonsick, E., et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007;102(3):919–25.

Sung, M.-K., Yeon, J.-Y., Park, S.-Y., Park, J. H. Y., and Choi, M.-S. Obesity-induced metabolic stresses in breast and colon cancer. Ann N Y Acad Sci. 2011;1229:61–8.

Nguyen, N. T., Magno, C. P., Lane, K. T., Hinojosa, M. W., and Lane, J. S. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J. Am. Coll. Surg. 2008;207(6):928–34.

[121] Hebert JR. Augustine A. Barone J. Kabat GC. Kinne DW. Wynder EL.   Weight, height and body mass index in the prognosis of breast cancer: early results of a prospective study. Int J Cancer. 1988; 42(3):315-8. Block s. 57

[122] Durak E. How exercise may help nutritionally. In: Cancer, Exercise, Wellness and Rehabilitation. Medical Health and Fitness: Santa Barbara, Ca. 1996; pp. 18-19

Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D; Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007 Dec 1;335(7630):1134.

Calle EE, Rodriguez C, Walker-Thrumond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively-studied cohort of US adults. N Engl J Med 2003;348(17):1625-38.

[123] Zhang, Y., Daquinag, A., Traktuev, D. O., et al. White Adipose Tissue Cells Are Recruited by Experimental Tumors and Promote Cancer Progression in Mouse Models. Cancer Res. 2009;69(12):5259–66

[124] Brown, K. A., and Simpson, E. R. Obesity and breast cancer: mechanisms and therapeutic implications. Front Biosci (Elite Ed). 2012;4:2515–24

Trayhurn, P., and Wood, I. S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem. Soc. Trans. 2005;33(Pt 5):1078–81

Schrager, M. A., Metter, E. J., Simonsick, E., et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007;102(3):919–25.

Mohamed-Ali, V., Goodrick, S., Rawesh, A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196–200

[125] Ortega Martinez de Victoria, E., Xu, X., Koska, J., et al. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes. 2009;58(2):385–93

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–808

[126] Sarfstein R, Pasmanik-Chor M, Yeheskel A, et al. Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells. J Biol Chem. 2012 Jan 20;287(4):2766-76.

[127] Laron Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. J Clin Pathol: Mol Pathol. 2001;54:311-16.

[128] Gajewska M, Zielniok K, Debski B, Motyl T. IGF-I retards proper development of acinar structures formed by bovine mammary epithelial cells via sustained activation of Akt kinase. Domest Anim Endocrinol. 2013 Oct;45(3):111-21.

[129] Roberts CT. IGF-1 and prostate cancer. Novartis Found Symp. 2004;262:193-9.

Emond JA, Pierce JP, Natarajan L, et al. Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGF-1 Receptor. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1273-9.

[130] Gajewska M, Zielniok K, Debski B, Motyl T. IGF-I retards proper development of acinar structures formed by bovine mammary epithelial cells via sustained activation of Akt kinase. Domest Anim Endocrinol. 2013 Oct;45(3):111-21.

[131] Vadgama JV, Wu Y, Datta G, Khan H, Chillar R. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology. 1999 Nov;57(4):330-40.

[132] Yee D. The insulin-like growth factor system as a treatment target in breast cancer. Seminars in Oncology. 29(3 Suppl 11):86-95, 2002

Oh JS. Kucab JE. Bushel PR. Martin K. Bennett L. Collins J. DiAugustine RP. Barrett JC. Afshari CA. Dunn SE. Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia (New York). 4(3):204-17, 2002

Lee AV. Cui X. Oesterreich S. Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer. Clinical Cancer Research. 7(12 Suppl):4429s-4435s, 2001

Zhang X, Yee D. Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Research. 2(3):170-5, 2000.

[133] Moschos SJ, Mantzoros CS. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology. 2002;63(4):317-32

Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). J Natl Cancer Inst. 2001;93(24):1852-7.

Beech DJ, Parekh N, Pang Y. Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol. Oncol Rep. 2001 Mar-Apr;8(2):325-9.

Singer CF, Hudelist G, Schreiber M, Kubista E. Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors. Drugs Today (Barc). 2003 Feb;39(2):115-25.

[134] Wolf I, Sadetzki S, Gluck I, Oberman B, Ben-David M, Papa MZ, Catane R, Kaufman B. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer. 2006 May;42(8):1077-82.

[135] Nihira S. Development of HER2-specific humanized antibody Herceptin (trastuzumab). Nippon Yakurigaku Zasshi. 2003 Dec;122(6):504-14.

[136] Moslen MT. Free Radicals in Diagnostic Medicine. New York: Plenum Press; 1994.

[137] Perwez Hussain S, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007 Dec 1;121(11):2373-80.

Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev. 2008 Jan;11(1):1-15.

[138] Yudoh K, Matsui H, Tsuji H. Nitric oxide induced by tumor cells activates tumor cell adhesion to endothelial cells and permeability of the endothelium in vitro. Clin Exp Metastasis. 1997 Nov;15(6):557-67.

Missirlis E, Whaley M, Lhotak S, Orr FW. Endothelial injury causes degradation of adjacent basement membranes and promotes their invasion by A549 carcinoma cells.

Invasion Metastasis. 1992;12(1):35-46.

[139] Saintot M, Mathieu-Daude H, Astre C, Grenier J, Simony-Lafontaine J, Gerber M. Oxidant-antioxidant status in relation to survival among breast cancer patients. Int J Cancer. 2002; 97(5):574-9. Block 2009

[140] Available at: http://www.stress.org/americas.htm. Accessed Feb. 4, 2012

[141] Matthews KA, Gump BB. Chronic work stress and marital dissolution increase risk of posttrial mortality in men from the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2002 Feb 11;162(3):309-15.

Veen G, Giltay EJ, DeRijk RH, van Vliet IM, van Pelt J, Zitman FG. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders. Metabolism. 2009 Jun;58(6):821-7.
Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010 May 28;141(2):122-31.
Heraclides A, Chandola T, Witte DR, Brunner EJ. Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: evidence from the Whitehall II study. Diabetes Care. 2009 Dec;32(12):2230-5.
Kruk J. Self-reported psychological stress and the risk of breast cancer: A case-control study. Stress. 2011 Aug 29.

[142] Wikgren M, Maripuu M, Karlsson T, et al. Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry. 2012 Feb 15;71(4):294-300.
Epel ES. Psychological and metabolic stress: A recipe for accelerated cellular aging? Hormones. 2009;8(1):7-22.
Houben JMJ, Mercken EM, Ketelslegers HB. Telomere shortening in chronic obstructive pulmonary disease. Respiratory Medicine. 2009;103:230-6.
Watfa G, Dragonas C, Brosche T, et al. Study of telomere length and different markers of oxidative stress in patients with Parkinson’s disease. Jour Nutr Health & Aging. 2011;15(4):227-81.
Tchirkov A, Lansdo PM. Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia–telangiectasia. Human Mol Gen. 2003;12(3):227-32.

[143] Samlet af Life Extension Foundation ud fra en række studier fra 2001-2011.

[144] Nilsson PM, Nilsson JA, Hedblad B, Berglund G. Sleep disturbance in association with elevated pulse rate for prediction of mortality–consequences of mental strain? J Intern Med. 2001 Dec;250(6):521-9.

[145] Nielsen NR, Kristensen TS, Schnohr P, Gronbaek M. Perceived stress and cause-specific mortality among men and women: results from a prospective cohort study. Am J Epidemiol. 2008 Sep 1;168(5):481-91; discussion 92-6.

[146] Brown DW, Anda RF, Tiemeier H, et al. Adverse childhood experiences and the risk of premature mortality. Am J Prev Med. 2009 Nov;37(5):389-96.

[147] Laszlo KD, Ahnve S, Hallqvist J, Ahlbom A, Janszky I. Job strain predicts recurrent events after a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med. 2010 Jun;267(6):599-611.

[148] Salavecz G, Chandola T, Pikhart H, et al. Work stress and health in Western European and post-communist countries: an East-West comparison study. J Epidemiol Community Health. 2010 Jan;64(1):57-62.

[149] Matthews KA, Gump BB. Chronic work stress and marital dissolution increase risk of posttrial mortality in men from the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2002 Feb 11;162(3):309-15.

[150] Kruk J. Self-reported psychological stress and the risk of breast cancer: A case-control study. Stress. 2011 Aug 29.

[151] Koolhaas J, Bartolomucci A, Buwalda B, et al. Stress revisited: A critical evaluation of the stress concept. Neurosci Biobehav Rev. 2011 Feb 21;35:1291-301.

[152] Opstad K. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur J Endocrinol. 1994;131:56-66.
Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response tocytokines in older adults. Health Psychol. 1994;13:291-8.

Epel ES. Psychological and metabolic stress: A recipe for accelerated cellular aging? Hormones. 2009;8(1):7-22.

[153] Wikgren M, Maripuu M, Karlsson T, et al. Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry. 2012 Feb 15;71(4):294-300.
Epel ES. Psychological and metabolic stress: A recipe for accelerated cellular aging? Hormones. 2009;8(1):7-22.
Houben JMJ, Mercken EM, Ketelslegers HB. Telomere shortening in chronic obstructive pulmonary disease. Respiratory Medicine. 2009;103:230-6.
Watfa G, Dragonas C, Brosche T, et al. Study of telomere length and different markers of oxidative stress in patients with Parkinson’s disease. Jour Nutr Health & Aging. 2011;15(4):227-81.
Tchirkov A, Lansdo PM. Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia–telangiectasia. Human Mol Gen. 2003;12(3):227-32.

[154] Opstad K. Circadian rhythm of hormones is extinguished during prolonged physical stress, sleep and energy deficiency in young men. Eur J Endocrinol. 1994;131:56-66.
Esterling BA, Kiecolt-Glaser JK, Bodnar JC, Glaser R. Chronic stress, social support, and persistent alterations in the natural killer cell response tocytokines in older adults. Health Psychol. 1994;13:291-8.

[155] Levy S, Herberman R, Lippman M, et al. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 1987 Mar;5(3):348-53.

[156] Ben Eliyahu S, Shakhar G, Page GG, et al. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation. 2000;8(3):154-64.

[157] Goodkin K, Antoni MH, Blaney PH. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J Psychosom Res. 1986;30(1):67-76.

Darmon P. [From cancers of the uterus and breast to cancers of the spirit (XVIII-XIX centuries)]. Contracept Fertil Sex. 1993 Feb;21(2):185-6.

[158] Maes M, Christophe A, Bosmans E, et al. In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry. 2000 May 15;47(10):910-20.

[159] Ben Eliyahu S, Page GG, Yirmiya R, et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999 Mar 15;80(6):880-8.

[160] Ader R, Grota LJ. Immunosuppressive effect of tetrahydrocannabinol plus cyclophosphamide. N Engl J Med. 1981 Aug 20;305(8):463.

Scanlan JM, Vitaliano PP, Zhang J, et al. Lymphocyte proliferation is associated with gender, caregiving, and psychosocial variables in older adults. J Behav Med. 2001 Dec;24(6):537-59.

[161] Richter R. Stress hormone may contribute to breast cancer deaths. Stanford Online Report 2000 Jun 28.2000;2000 Jun 28 .

[162] Hamer M, Owen G, Kloek J. The role of functional foods in the psychobiology of health and disease. Nutr Res Rev. 2005 Jun;18(1):77-88.

Kimura K, Ozeki M, Juneja LR, Ohira H. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007 Jan;74(1):39-45.

[163] Travlos GS, Wilson RE, Murrell JA, et al. The effect of short intermittent light exposures on the melatonin circadian rhythm and NMU-induced breast cancer in female F344/N rats. Toxicol Pathol. 2001 Jan;29(1):126-36.

[164] Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997 Jan 17;70(2):241-7.
Roenneberg T, Lucas RJ. Light, endocrine systems, and cancer–a view from circadian biologists. Neuroendocrinol Lett. 2002 Jul;23 Suppl 2:82-3.

[165] Sephton SE, Sapolsky RM, Kraemer HC, et al. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000 Jun 21;92(12):994-1000.

[166] Schernhammar, ES., Laden, F., Speizer, FE. Et al.: Rotating nighht shifts and risk of breast cancer in women participating in the Nurses´Health Study. J Natll Cancer Inst 2001; 93: 1563-68.

Davis, S., Mirick, DK., Stevens, RG.: Night shift work, light at night and risk of breast cancer. J Natl Cancer Inst 2001; 93: 157-62. Her i: Michael Murray et al. Op cit. s. 78

[167] Working the Night Shift May Boost Breast Cancer Risk. http://healthland.time.com/2012/05/29/working-the-night-shift-may-boost-breast-cancer-risk/

[168] http://www.lef.org/whatshot/2008_07.htm#Breast-cancer-risk-associated-less-sleep-large-study-population

[169] The Journal of the National Cancer Institute 17.8.2001

[170] Cohen L, Warneke C, Fouladi RT, Rodriguez MA, Chaoul-Reich A. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma. Cancer. 2004;100(10):2253-60.

Mansky, P., Sannes, T., Wallerstedt, D., Ge, A., Ryan, M., Johnson, L.L., Chesney, M. & Gerber, L. (2006). Tai chi chuan: mind-body practice or exercise intervention? Studying the benefit for cancer survivors. Integrative Cancer Therapies 5(3), 192-201

Bower, J.E., Woolery, A., Sternlieb, B. & Garet, D. (2005). Yoga for cancer patients and survivors. Cancer Control 12(3), 165-171.

Visovsky, C. (2006). Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integrative Cancer Therapies 5(3), 183-191. Block s. 161